Preparation and evaluation of chicken embryo-adapted fowl adenovirus serotype 4 vaccine in broiler chickens

被引:0
作者
Muhammad Khalid Mansoor
Iftikhar Hussain
Muhammad Arshad
Ghulam Muhammad
机构
[1] University of Agriculture,Department of Microbiology, Faculty of Veterinary Science
[2] University of Agriculture,Department of Clinical Medicine and Surgery, Faculty of Veterinary Science
来源
Tropical Animal Health and Production | 2011年 / 43卷
关键词
Hydropericardium syndrome; Fowl adenovirus serotype 4; Attenuated vaccine; Hexon gene;
D O I
暂无
中图分类号
学科分类号
摘要
The current study was planned to develop an efficient vaccine against hydropericardium syndrome virus (HSV). Currently, formalin-inactivated liver organ vaccines failed to protect the Pakistan broiler industry from this destructive disease of economic importance. A field isolate of the pathogenic hydropericardium syndrome virus was adapted to chicken embryos after four blind passages. The chicken embryo-adapted virus was further serially passaged (12 times) to get complete attenuation. Groups of broiler chickens free from maternal antibodies against HSV at the age of 14 days were immunized either with 16th passage attenuated HSV vaccine or commercially formalized liver organ vaccine. The antibody response, measured by enzyme-linked immunosorbent assay was significantly higher (P < 0.05) in the group immunized with the 16th passage attenuated HSV vaccine compared to the group immunized with liver organ vaccine at 7, 14, and 21 days post-immunization. At 24 days of age, the broiler chickens in each group were challenged with 103.83 embryo infectious dose50 of pathogenic HSV and were observed for 7 days post-challenge. Vaccination with the 16th passage attenuated HSV gave 94.73% protection as validated on the basis of clinical signs (5.26%), gross lesions in the liver and heart (5.26%), histopathological lesions in the liver (1.5 ± 0.20), and mortality (5.26%). The birds inoculated with liver organ vaccine showed significantly low (p < 0.05; 55%) protection estimated on the basis of clinical signs (40%), gross lesions in the liver and heart (45%), histopathological lesions in the liver (2.7 ± 0.72), and mortality (35%). Birds in the unvaccinated control group showed high morbidity (84%), mortality (70%), gross (85%), and histopathological lesions (3.79 ± 0.14) with only 10% protection. In conclusion, this newly developed HSV vaccine proved to be immunogenic and has potential for controlling HSV infections in chickens.
引用
收藏
页码:331 / 338
页数:7
相关论文
共 138 条
[1]  
Abdul-Aziz TA(1991)New syndrome in Iraqi chicks Veterinary Record 129 272-60
[2]  
Al-Attar MA(1990)Efficacy of an inactivated vaccine against hydropericardium syndrome in broilers Veterinary Record 126 59-138
[3]  
Afzal M(1990)Efficacy of formalized liver organ vaccine against angara disease in broiler Veterinary Archive 63 131-1314
[4]  
Ahmad I(2000)Comparative immune response of formalin inactivated and binary ethyleneimine inactivated Angara disease vaccines Pakistan Journal Biology Science 3 1313-787
[5]  
Ahmad K(2001)Genomic identification and characterization of avian adenovirus associated with inclusion body hepatitis Avian Diseases 45 780-248
[6]  
Malik MI(1989)Hydropericarditis syndrome in broiler chickens in Pakistan Veterinary Record 124 247-795
[7]  
Iqbal K(1989)An adenovirus infection of poultry in Pakistan Review of Science and Technology Office International des Epizooties 8 789-352
[8]  
Ahmad K(1988)Chicken embryo propagation of type I avian adenoviruses Avian Diseases 32 347-42
[9]  
Naz S(1955)Multiple range and multiple F tests Biometrics 11 1-534
[10]  
Akhtar M(1975)Antigenic characterization of the inclusion body hepatitis virus American Journal of Veterinary Research 36 532-196